8 research outputs found
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
BACKGROUND: Temprano ANRS 12136 was a factorial 2âĂâ2 trial that assessed the benefits of early antiretroviral therapy (ART; ie, in patients who had not reached the CD4 cell count threshold used to recommend starting ART, as per the WHO guidelines that were the standard during the study period) and 6-month isoniazid preventive therapy (IPT) in HIV-infected adults in CĂŽte d'Ivoire. Early ART and IPT were shown to independently reduce the risk of severe morbidity at 30 months. Here, we present the efficacy of IPT in reducing mortality from the long-term follow-up of Temprano. METHODS: For Temprano, participants were randomly assigned to four groups (deferred ART, deferred ART plus IPT, early ART, or early ART plus IPT). Participants who completed the trial follow-up were invited to participate in a post-trial phase. The primary post-trial phase endpoint was death, as analysed by the intention-to-treat principle. We used Cox proportional models to compare all-cause mortality between the IPT and no IPT strategies from inclusion in Temprano to the end of the follow-up period. FINDINGS: Between March 18, 2008, and Jan 5, 2015, 2056 patients (mean baseline CD4 count 477 cells per ÎŒL) were followed up for 9404 patient-years (Temprano 4757; post-trial phase 4647). The median follow-up time was 4·9 years (IQR 3·3-5·8). 86 deaths were recorded (Temprano 47 deaths; post-trial phase 39 deaths), of which 34 were in patients randomly assigned IPT (6-year probability 4·1%, 95% CI 2·9-5·7) and 52 were in those randomly assigned no IPT (6·9%, 5·1-9·2). The hazard ratio of death in patients who had IPT compared with those who did not have IPT was 0·63 (95% CI, 0·41 to 0·97) after adjusting for the ART strategy (early vs deferred), and 0·61 (0·39-0·94) after adjustment for the ART strategy, baseline CD4 cell count, and other key characteristics. There was no evidence for statistical interaction between IPT and ART (pinteraction=0·77) or between IPT and time (pinteraction=0·94) on mortality. INTERPRETATION: In CĂŽte d'Ivoire, where the incidence of tuberculosis was last reported as 159 per 100â000 people, 6 months of IPT has a durable protective effect in reducing mortality in HIV-infected people, even in people with high CD4 cell counts and who have started ART. FUNDING: National Research Agency on AIDS and Viral Hepatitis (ANRS)
Effect Of Kombucha On The Cardiovascular System Of Mammals
Kombucha, a traditional beverage mushroom containing a symbiotic bacteria, is prepared with sweetened tea of (Theaceae) and is often drank in many parts of the world. The aim of this study was to investigate the effects of this beverage on cardiovascular system of rodents, rat and rabbit. Therefore, we measured the blood pressure of the rabbit, and the frequency and the amplitude of heart beat of the rat. On an isolated heart of rat, kombucha induced a cardio-depressive effect, meaning a negative inotropic and chronotropic effects. The inhibitory concentration 50% was 15mg/ml. kombucha induced a dose dependent reduction in blood pressure followed by a non dose dependent increase in blood pressure in the range 50- 1800mg/kg.Above 1800mg/kg we noticed a lower decrease of the blood pressure. The low blood pressure effect of kombucha is inhibited by Acetylcholine effect. Atropine partially inhibited the negative inotopic effect of kombucha. And kombucha partially inhibited the catalytic activity of acetylcholinesterase.Keywords: Kombucha, Heart activity, blood arterial pressure,Acetylcholinesterase, rat, rabbi